We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron, Vir Prepare for COVID-19 Antibody Trials, Warn of Manufacturing Challenges
Regeneron, Vir Prepare for COVID-19 Antibody Trials, Warn of Manufacturing Challenges
Regeneron Pharmaceuticals and Vir Biotechnology said they will soon begin clinical trials of monoclonal antibodies they hope will be able to prevent or treat COVID-19 patients.